Global Good Investment Case for Lateral Flow Assays (LFAs) for Neglected Tropical Diseases (NTD)

By August 21, 2019 September 10th, 2019 Global Diseases, Innovations and Diagnostics

Ultrasensitive antigen tests are needed for early detection of numerous infectious diseases, and for surveillance and monitoring progress towards disease elimination. GHIG and IDC/LSHTM are working with the Global Good Fund and Intellectual Ventures Laboratory to improve and expand LFA technologies to a wide range of infectious and potentially non-infectious diseases with high burden in low-and middle-income countries.